Lakeshore Biopharma Co. Ltd.Preferred / convertible
13F holders, Q2 2024 (June 30)23holders −2
0new positions
2sold out
1famous investor
$0.10avg. 13F price*
At the end of Q2 2024, 23 institutions reported holding Lakeshore Biopharma Co. Ltd. in their 13F filings, down 2 from Q1 2024. 0 opened new positions and 2 sold out. The largest holders were LMR Partners LLP ($93K), Athos Capital Ltd ($84K) and Valliance Asset Management Ltd ($66K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Lakeshore Biopharma Co. Ltd.
- CUSIP
- G9845F117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $1K |
All 13F filers, Q1 2024 → Q2 2024: 2,208 shares bought and 25,520 shares sold, net −23,312 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| LMR Partners LLP | — | No change | 1,052,461 | $93K |
| Athos Capital Ltd | — | No change | 128,981 | $84K |
| Valliance Asset Management Ltd | — | No change | 750,000 | $66K |
| Jane Street Group, LLC | — | No change | 498,301 | $44K |
| BFAM Partners (Cayman) Ltd | — | — | 550,000 | $37K |
| Finepoint Capital LP | — | No change | 489,999 | $33K |
| Bracebridge Capital, LLC | — | No change | 232,323 | $20K |
| Cowen and Company, LLC | — | Reduce -1.5% | 231,999 | $20K |
| Whitebox Advisors LLC | — | No change | 125,000 | $11K |
| Q Global Advisors, LLC | — | No change | 130,600 | $11K |
| Calamos Advisors LLC | — | No change | 146,040 | $10K |
| D. E. Shaw & Co. | — | No change | 100,000 | $9K |
| Walleye Capital LLC | — | No change | 99,905 | $9K |
| Cantor Fitzgerald, L. P. | — | No change | 76,931 | $7K |
| Shaolin Capital Management LLC | — | No change | 76,200 | $7K |
| Saba Capital Management, L.P. | — | No change | 97,299 | $5K |
| Exos Asset Management LLC | — | No change | 50,000 | $4K |
| Clear Street LLC | — | Add +4.7% | 49,494 | $4K |
| Meteora Capital, LLC | — | No change | 25,000 | $2K |
| SkyView Investment Advisors, LLC | — | No change | 12,210 | $1K |
| Ancora Advisors LLC | — | No change | 5,050 | $444 |
| HGC Investment Management Inc. | — | No change | 5,000 | $440 |
| Tower Research Capital LLC (TRC) | — | No change | 126 | $11 |
"% of holder's portfolio" is LAKESHORE BIOPHARMA CO LTD's weight in each manager's 13F, not the share of Lakeshore Biopharma Co. Ltd. the manager owns.